Trial Profile
Effectiveness of golimumab for the treatment of ulcerative colitis in italian patient with inflammatory bowel disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 06 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week